CNBC's Charlotte Reed will travel to Copenhagen to speak with Novo Nordisk's new CEO after a bumpy few months.

Brokerages including Jefferies, Citi, Goldman Sachs, JP Morgan and UBS have given a Buy rating on Cipla, ITC, Pidilite, DLF, ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), announced that Nanoviricides CEO Dr Anil Diwan joined ...

The lawsuit escalates an unusual, high-profile battle between two large pharmaceutical companies over ownership of a coveted ...

Eli Lilly delivered a stunning financial performance that exceeded even the most optimistic market expectations, driven by unprecedented demand for its ...

But last week, those words took on the force of law. On Tuesday, Texas Attorney General Ken Paxton filed a lawsuit against ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

Bugonia tells the story of a conspiracy theorist abducting a CEO, believing her to be an alien. However, things turn out wilder than his expectations.

Gov. Glenn Youngkin announced a landmark partnership Friday with AstraZeneca, Lilly and Merck to create the nation’s largest ...

Here’s some encouraging news, though. Thanks to a major investment in Seymour, Guardian Bikes is currently building the first large-scale bicycle frame manufacturing operation in the United States. It ...

Over the past few decades, the Triangle’s life sciences sector has been a monolithic growth engine, but now it’s bifurcated.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the Best Beaten Down Growth Stocks to Buy According to Analysts.